Annual Cash & Cash Equivalents
$34.10 M
+$10.24 M+42.93%
30 November 2023
Summary:
Theratechnologies annual cash & cash equivalents is currently $34.10 million, with the most recent change of +$10.24 million (+42.93%) on 30 November 2023. During the last 3 years, it has risen by +$21.36 million (+167.70%). THTX annual cash & cash equivalents is now -12.57% below its all-time high of $39.00 million, reached on 30 November 2018.THTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$34.69 M
+$3.52 M+11.31%
31 August 2024
Summary:
Theratechnologies quarterly cash and cash equivalents is currently $34.69 million, with the most recent change of +$3.52 million (+11.31%) on 31 August 2024. Over the past year, it has increased by +$19.72 million (+131.79%). THTX quarterly cash and cash equivalents is now -29.37% below its all-time high of $49.12 million, reached on 28 February 2021.THTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
THTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.9% | +131.8% |
| 3 y3 years | +167.7% | +6.9% |
| 5 y5 years | -12.6% | +11.8% |
THTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +167.7% | at high | +162.8% |
| 5 y | 5 years | -12.6% | +167.7% | -29.4% | +172.4% |
| alltime | all time | -12.6% | >+9999.0% | -29.4% | >+9999.0% |
Theratechnologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2024 | - | $34.69 M(+11.3%) |
| May 2024 | - | $31.17 M(-3.3%) |
| Feb 2024 | - | $32.24 M(-5.4%) |
| Nov 2023 | $34.10 M(+42.9%) | $34.10 M(+127.8%) |
| Aug 2023 | - | $14.97 M(-11.7%) |
| May 2023 | - | $16.96 M(-15.3%) |
| Feb 2023 | - | $20.02 M(-16.1%) |
| Nov 2022 | $23.86 M(+16.9%) | $23.86 M(+1.9%) |
| Aug 2022 | - | $23.42 M(+77.4%) |
| May 2022 | - | $13.20 M(-8.0%) |
| Feb 2022 | - | $14.34 M(-29.7%) |
| Nov 2021 | $20.40 M(+60.2%) | $20.40 M(-37.1%) |
| Aug 2021 | - | $32.45 M(-15.1%) |
| May 2021 | - | $38.23 M(-22.2%) |
| Feb 2021 | - | $49.12 M(+285.6%) |
| Nov 2020 | $12.74 M(-55.6%) | $12.74 M(-26.1%) |
| Aug 2020 | - | $17.24 M(-19.6%) |
| May 2020 | - | $21.44 M(-9.2%) |
| Feb 2020 | - | $23.60 M(-17.7%) |
| Nov 2019 | $28.66 M(-26.5%) | $28.66 M(-7.6%) |
| Aug 2019 | - | $31.03 M(+3.1%) |
| May 2019 | - | $30.09 M(-25.1%) |
| Feb 2019 | - | $40.19 M(+3.1%) |
| Nov 2018 | $39.00 M(+2756.9%) | $39.00 M(+13.1%) |
| Aug 2018 | - | $34.48 M(+1367.0%) |
| May 2018 | - | $2.35 M(+73.0%) |
| Feb 2018 | - | $1.36 M(-0.4%) |
| Nov 2017 | $1.36 M(+73.2%) | $1.36 M(+33.8%) |
| Aug 2017 | - | $1.02 M(-66.2%) |
| May 2017 | - | $3.02 M(-45.1%) |
| Feb 2017 | - | $5.50 M(+598.4%) |
| Nov 2016 | $788.20 K(-93.1%) | $788.20 K(+222.5%) |
| Aug 2016 | - | $244.40 K(-93.3%) |
| May 2016 | - | $3.63 M(-56.6%) |
| Feb 2016 | - | $8.35 M(-27.3%) |
| Nov 2015 | $11.48 M(+1794.7%) | $11.48 M(+0.2%) |
| Aug 2015 | - | $11.46 M(+211.6%) |
| May 2015 | - | $3.68 M(+16.1%) |
| Feb 2015 | - | $3.17 M(+423.0%) |
| Nov 2014 | $605.90 K(-33.5%) | $605.90 K(-73.9%) |
| Aug 2014 | - | $2.32 M(+712.1%) |
| May 2014 | - | $285.70 K(+34.1%) |
| Feb 2014 | - | $213.00 K(-76.6%) |
| Nov 2013 | $910.80 K(-40.2%) | $910.80 K(-40.9%) |
| Aug 2013 | - | $1.54 M(+294.0%) |
| May 2013 | - | $391.00 K(+406.5%) |
| Feb 2013 | - | $77.20 K(-94.9%) |
| Nov 2012 | $1.52 M(-38.6%) | $1.52 M(-40.6%) |
| Aug 2012 | - | $2.56 M(+153.3%) |
| May 2012 | - | $1.01 M(+1495.0%) |
| Feb 2012 | - | $63.40 K(-97.4%) |
| Nov 2011 | $2.48 M(-90.5%) | $2.48 M(+380.4%) |
| Aug 2011 | - | $515.90 K(-50.1%) |
| May 2011 | - | $1.03 M(+90.1%) |
| Feb 2011 | - | $544.00 K(-97.9%) |
| Nov 2010 | $26.14 M | $26.14 M(+1069.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2010 | - | $2.23 M(-32.6%) |
| May 2010 | - | $3.31 M(+4.6%) |
| Feb 2010 | - | $3.17 M(+120.7%) |
| Nov 2009 | $1.44 M(+1240.9%) | $1.44 M(-87.6%) |
| Aug 2009 | - | $11.62 M(+230.3%) |
| May 2009 | - | $3.52 M(-35.2%) |
| Feb 2009 | - | $5.43 M(+4968.1%) |
| Nov 2008 | $107.10 K(-95.8%) | $107.10 K(-98.8%) |
| Aug 2008 | - | $9.05 M(+12.7%) |
| May 2008 | - | $8.03 M(-54.8%) |
| Feb 2008 | - | $17.74 M(+588.5%) |
| Nov 2007 | $2.58 M(>+9900.0%) | $2.58 M(-58.4%) |
| Aug 2007 | - | $6.19 M(-47.6%) |
| May 2007 | - | $11.83 M(-74.8%) |
| Feb 2007 | - | $47.01 M(>+9900.0%) |
| Nov 2006 | $14.00 K(-98.5%) | $14.00 K(-99.0%) |
| Aug 2006 | - | $1.40 M(-9.6%) |
| May 2006 | - | $1.55 M(+2417.9%) |
| Feb 2006 | - | $61.50 K(-93.4%) |
| Nov 2005 | $930.70 K(+153.5%) | $930.70 K(-76.8%) |
| Aug 2005 | - | $4.02 M(-33.7%) |
| May 2005 | - | $6.06 M(+34.6%) |
| Feb 2005 | - | $4.50 M(+1125.4%) |
| Nov 2004 | $367.20 K(+800.0%) | $367.20 K(+6.2%) |
| Aug 2004 | - | $345.90 K(-86.9%) |
| May 2004 | - | $2.63 M(-83.5%) |
| Feb 2004 | - | $15.94 M(>+9900.0%) |
| Nov 2003 | $40.80 K(-67.4%) | $40.80 K(-97.9%) |
| Aug 2003 | - | $1.90 M(-56.4%) |
| May 2003 | - | $4.36 M(+30.7%) |
| Feb 2003 | - | $3.33 M(+2561.7%) |
| Nov 2002 | $125.20 K(-91.9%) | $125.20 K(-98.7%) |
| Aug 2002 | - | $9.57 M(+34.7%) |
| May 2002 | - | $7.11 M(-45.6%) |
| Feb 2002 | - | $13.06 M(+741.7%) |
| Nov 2001 | $1.55 M(+75.8%) | $1.55 M(-92.4%) |
| Aug 2001 | - | $20.52 M(+188.0%) |
| May 2001 | - | $7.13 M(+506.9%) |
| Feb 2001 | - | $1.17 M(+33.0%) |
| Nov 2000 | $882.60 K(+225.0%) | $882.60 K(-92.5%) |
| Aug 2000 | - | $11.76 M(-3.2%) |
| May 2000 | - | $12.15 M(+529.5%) |
| Feb 2000 | - | $1.93 M(+610.5%) |
| Nov 1999 | $271.60 K(-97.4%) | $271.60 K(-98.3%) |
| Aug 1999 | - | $15.99 M(+21.5%) |
| May 1999 | - | $13.16 M(+40.8%) |
| Feb 1999 | - | $9.35 M(-9.7%) |
| Nov 1998 | $10.35 M(+48.8%) | $10.35 M(+1.0%) |
| Aug 1998 | - | $10.25 M(-9.5%) |
| May 1998 | - | $11.33 M(+99.0%) |
| Feb 1998 | - | $5.69 M(-18.2%) |
| Nov 1997 | $6.96 M(-8.1%) | $6.96 M(-16.7%) |
| Aug 1997 | - | $8.35 M(+4.6%) |
| May 1997 | - | $7.98 M(-17.2%) |
| Feb 1997 | - | $9.64 M |
| Nov 1996 | $7.57 M | - |
FAQ
- What is Theratechnologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Theratechnologies?
- What is Theratechnologies annual cash & cash equivalents year-on-year change?
- What is Theratechnologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Theratechnologies?
- What is Theratechnologies quarterly cash and cash equivalents year-on-year change?
What is Theratechnologies annual cash & cash equivalents?
The current annual cash & cash equivalents of THTX is $34.10 M
What is the all time high annual cash & cash equivalents for Theratechnologies?
Theratechnologies all-time high annual cash & cash equivalents is $39.00 M
What is Theratechnologies annual cash & cash equivalents year-on-year change?
Over the past year, THTX annual cash & cash equivalents has changed by +$10.24 M (+42.93%)
What is Theratechnologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of THTX is $34.69 M
What is the all time high quarterly cash and cash equivalents for Theratechnologies?
Theratechnologies all-time high quarterly cash and cash equivalents is $49.12 M
What is Theratechnologies quarterly cash and cash equivalents year-on-year change?
Over the past year, THTX quarterly cash and cash equivalents has changed by +$19.72 M (+131.79%)